Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19
Yıl: 2020 Cilt: 42 Sayı: 4 Sayfa Aralığı: 494 - 495 Metin Dili: İngilizce DOI: 10.14744/etd.2020.73483 İndeks Tarihi: 17-02-2022
Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
- 1. Özdemir Ö, Arsoy HEM. Convalescent (Immune) Plasma Therapy with all Aspects: Yesterday, Today and COVID-19. Erciyes Med J 2020; 42(3): 252–9.
- 2. Wiwanitkit V. Convalescent (immune) plasma therapy and COVID19. Erciyes Med J 2020; 42(4): 493.
- 3. Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A 2020; 117(17): 9490–6.
- 4. Rajendran K, Krishnasamy N, Rangarajan J, Rathinam J, Natarajan M, Ramachandran A. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. J Med Virol. 2020 May 1:10.1002/jmv.25961. doi: 10.1002/jmv.25961. [Epub ahead of print].
- 5. Huang J, Zheng L, Li Z, Hao S, Ye F, Chen J, et al. Recurrence of SARS-CoV-2 PCR positivity in COVID-19 patients: a single center experience and potential implications. MedRxiv. May 10, 2020. doi: https://doi.org/10.1101/2020.05.06.20089573. [Ahead of print].
- 6. Kang H, Wang Y, Tong Z, Liu X. Retest positive for SARS-CoV-2 RNA of “recovered” patients with COVID-19: Persistence, sampling issues, or re-infection? J Med Virol. June 03, 2020. doi: https://doi. org/10.1002/jmv.26114. [Ahead of print].
- 7. Bao L, Deng W, Gao H, Xiao C, Liu J, Xue J, et al. Reinfection could not occur in SARS-CoV-2 infected rhesus macaques. BioRxiv. March 14, 2020. doi: https://doi.org/10.1101/2020.03.13.990226. [Ahead of print].
| APA | Özdemir Ö (2020). Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19. , 494 - 495. 10.14744/etd.2020.73483 |
| Chicago | Özdemir Öner Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19. (2020): 494 - 495. 10.14744/etd.2020.73483 |
| MLA | Özdemir Öner Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19. , 2020, ss.494 - 495. 10.14744/etd.2020.73483 |
| AMA | Özdemir Ö Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19. . 2020; 494 - 495. 10.14744/etd.2020.73483 |
| Vancouver | Özdemir Ö Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19. . 2020; 494 - 495. 10.14744/etd.2020.73483 |
| IEEE | Özdemir Ö "Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19." , ss.494 - 495, 2020. 10.14744/etd.2020.73483 |
| ISNAD | Özdemir, Öner. "Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19". (2020), 494-495. https://doi.org/10.14744/etd.2020.73483 |
| APA | Özdemir Ö (2020). Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19. Erciyes Medical Journal, 42(4), 494 - 495. 10.14744/etd.2020.73483 |
| Chicago | Özdemir Öner Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19. Erciyes Medical Journal 42, no.4 (2020): 494 - 495. 10.14744/etd.2020.73483 |
| MLA | Özdemir Öner Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19. Erciyes Medical Journal, vol.42, no.4, 2020, ss.494 - 495. 10.14744/etd.2020.73483 |
| AMA | Özdemir Ö Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19. Erciyes Medical Journal. 2020; 42(4): 494 - 495. 10.14744/etd.2020.73483 |
| Vancouver | Özdemir Ö Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19. Erciyes Medical Journal. 2020; 42(4): 494 - 495. 10.14744/etd.2020.73483 |
| IEEE | Özdemir Ö "Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19." Erciyes Medical Journal, 42, ss.494 - 495, 2020. 10.14744/etd.2020.73483 |
| ISNAD | Özdemir, Öner. "Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19". Erciyes Medical Journal 42/4 (2020), 494-495. https://doi.org/10.14744/etd.2020.73483 |
